CELC241220P10000
- 0.45
- 0.000.00%
Celcuity Newsroom
Analysts Have Conflicting Sentiments on These Healthcare Companies: Hims & Hers Health (HIMS) and Celcuity (CELC)
A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $27 to $42
Celcuity Price Target Maintained With a $27.00/Share by HC Wainwright & Co.
Stifel Nicolaus Remains a Buy on Celcuity (CELC)
A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $23 to $27
Celcuity's Strong Financial Position and Promising Drug Pipeline Support Buy Rating Despite Trial Delays
Needham Reiterates Buy on Celcuity, Maintains $23 Price Target
Celcuity Analyst Ratings
Craig-Hallum Maintains Celcuity(CELC.US) With Buy Rating
Craig-Hallum Maintains Celcuity(CELC.US) With Buy Rating
Craig-Hallum Maintains Celcuity(CELC.US) With Buy Rating
Celcuity (CELC) Gets a Buy From Craig-Hallum
Celcuity Is Maintained at Buy by Stifel
Stifel Maintains Celcuity(CELC.US) With Buy Rating, Raises Target Price to $42
Celcuity Price Target Announced at $27.00/Share by LifeSci Capital
Celcuity Analyst Ratings
LifeSci Capital Initiates Coverage on Celcuity With Outperform Rating, $27 Price Target
A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $23 to $39
A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $23 to $39
Celcuity Price Target Maintained With a $27.00/Share by HC Wainwright & Co.